FDA Drug Program Leader Steps Down Amid Ongoing Agency Shake‑Ups
The Food and Drug Administration has announced that its chief drug official will leave her post, adding to a series of recent changes at the agency. Dr. Tracy Beth Hoeg, who has overseen investigations into antidepressants, COVID‑19 vaccines and other common medicines, will be replaced by Dr. Mike D